OpenVSafe by OpenVAERS
Search V-safe

YSL-25408-38609

2 vaccinations 5 coded responses 14 check-ins 5 free-text entries 2 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
371 / TN
Registered
2021-01-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-23
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-18
    Registered in v-safe
  3. 2021-01-18
    Dose 2 — Pfizer-BioNTech
  4. 2021-01-18
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  5. 2021-01-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling · None
    Adult check-in
  6. 2021-01-21
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling, Injection site warmth — Feeling: Good · Site: Pain, Swelling
    Free text: The injection site redness was present yesterday (day 2 post injection) but is gone today. There is, however, a swollen area that remains slightly warm and is firm to the touch. It is very slightly tender.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-01-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site swelling — Feeling: Good · Site: Swelling
    Free text: The injection site remains swollen/firm, but the diameter of the circular are is smaller and it is less warm.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site induration — Feeling: Good
    Free text: Firm area at site of injection, now about fingertip size, remains.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-01-25
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-02-02
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-02-08
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-02-15
    Survey response — day 28, dose 2
    MedDRA: Constipation, Medical counselling — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Constipation · Healthcare visit (other): After hours phone consultation
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-02-15
    Report sent to call center — day 28, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  14. 2021-02-22
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-03-01
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-04-19
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-07-19
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-08-03
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  19. 2022-01-18
    Survey response — 12 months, dose 2
    MedDRA: Anxiety, Decreased appetite, Dizziness, Feeling cold, Heart rate increased, Palpitations — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Palpitations and dizziness, combined with a sense of dread/vulnerability, being unusually cold (but not feverish), no appetite. Several instances of pounding, rapid heartbeat.
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-01-18
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · 1 call case(s)
  21. 2022-01-19

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Pfizer-BioNTech
22021-01-18Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-02-15 Successful
2021-08-03
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-01-18 Unsuccessful

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-21

Systemic reaction (other): The injection site redness was present yesterday (day 2 post injection) but is gone today. There is, however, a swollen area that remains slightly warm and is firm to the touch. It is very slightly tender.

2021-01-22

Systemic reaction (other): The injection site remains swollen/firm, but the diameter of the circular are is smaller and it is less warm.

2021-01-24

Systemic reaction (other): Firm area at site of injection, now about fingertip size, remains.

Release 4 — day 28, dose 2

2021-02-15

Symptoms: Constipation
Healthcare visit (other): After hours phone consultation

Release 10 — 12 months, dose 2

2022-01-18

Symptoms: Palpitations and dizziness, combined with a sense of dread/vulnerability, being unusually cold (but not feverish), no appetite. Several instances of pounding, rapid heartbeat.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling ✓ ✓ ✓
SDAnxiety · · ✓
SDConstipation ✓ ✓ ✓
SDDecreased appetite · · ✓
SDDizziness · · ✓
SDFeeling cold · · ✓
SDHeart rate increased · · ✓
SDPalpitations · · ✓
SROInjection site erythema ✓ ✓ ✓
SROInjection site induration ✓ ✓ ✓
SROInjection site nodule ○ ○ ○
SROInjection site pain ✓ ✓ ✓
SROInjection site swelling ✓ ✓ ✓
SROInjection site warmth ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release